Yoichi Imai

10PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Veterinary mycologyMolecular targetsHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 11, 2024
Novel treatment strategies for hematological malignancies in the immunotherapy era.

Yoichi Imai

|Aug 26, 2023
Current and Future PET Imaging for Multiple Myeloma.

Mariko Ishibashi, Miwako Takahashi, Taiga Yamaya

|Dec 26, 2022
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani

|Dec 13, 2021
RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.

Tatsuya Masuda, Shintaro Maeda, Sae Shimada

|Jul 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

Hiroshi Yasui, Masayuki Kobayashi, Kota Sato

|Sep 18, 2020
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

Norina Tanaka, Yoichi Imai, Kentaro Yoshinaga

Pageof 2

Frequent Collaborators

2 joint publications

Yasuhiko Kamikubo

1 joint publications

Hiroshi Handa

1 joint publications

Takeshi Imai

1 joint publications

Shintaro Maeda